Needham maintains Equifax at Buy, raises price target to $220 from $210
Needham reaffirmed its Buy rating for Equifax and increased its price target to $220 from $210, citing a 16.9% upside from the Nov 13 close of $188.12. Recent analyst price targets for Equifax range from $175 to $217.
How this was made

The 30-second read
Why it matters
The upward revision signals confidence in earnings growth or market positioning, which could prompt buying interest.
Market read
A new analyst price target can move the stock modestly, offering a short‑term trading cue.
What to watch
Potential regulatory scrutiny on credit bureaus could offset the bullish signal.
Background
Equifax (EFX) is a leading consumer credit reporting agency. Analyst price target changes often influence short‑term sentiment.
Ticker impact
Needham raised Equifax's price target to $220 from $210, indicating a bullish outlook.
likely upward pressure as investors price in the higher target
The new target implies a 16.9% upside from the recent close, which may attract buying.
Market effects
Credit reporting sector may see modest uplift as a major player receives a higher target.
U.S. markets could see slight positive bias in financial services stocks.
Limited to investors tracking U.S. credit data providers.
Counterpoint
The target raise may already be priced in, limiting upside.
Key entities
- analystNeedham & Company
Equity research firm that issued the rating and target update.
- companyEquifax Inc.
U.S. consumer credit reporting company.


